Evidence map›Paper›PMID 30244523›Full record

ArticleAging cell2018

Telomere dysfunction promotes transdifferentiation of human fibroblasts into myofibroblasts.

Neetu Razdan, Themistoklis Vasilopoulos, Utz Herbig

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. New intranasal and injectable gene therapy for healthy life extension.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Neetu RazdanNew Jersey Medical School, Cancer Institute of New Jersey-Newark, Rutgers Biomedical and Health Sciences, Newark, New Jersey.
Themistoklis VasilopoulosNew Jersey Medical School, Cancer Institute of New Jersey-Newark, Rutgers Biomedical and Health Sciences, Newark, New Jersey.
Utz HerbigNew Jersey Medical School, Cancer Institute of New Jersey-Newark, Rutgers Biomedical and Health Sciences, Newark, New Jersey.
Rutgers HealthRutgers, The State University of New Jersey · US

Funding

Tumor Suppression by Telomere Dysfunction Induced SenescenceR01CA136533 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI HERBIG, UTZ · 2010 to 2021
$3.7M
(PQB-4) Opposing Effects of the SASP in Cancer ProgressionR01CA184572 · NCI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI HERBIG, UTZ · 2014 to 2017
$1.3M
NCI NIH HHS R01 CA136533NCI NIH HHS R01 CA184572
6 · The paper itself

Abstract

Cells that had undergone telomere dysfunction-induced senescence secrete numerous cytokines and other molecules, collectively called the senescence-associated secretory phenotype (SASP). Although certain SASP factors have been demonstrated to promote cellular senescence in neighboring cells in a paracrine manner, the mechanisms leading to bystander senescence and the functional significance of these effects are currently unclear. Here, we demonstrate that TGF-β1, a component of the SASP, causes telomere dysfunction in normal somatic human fibroblasts in a Smad3/NOX4/ROS-dependent manner. Surprisingly, instead of activating cellular senescence, TGF-β1-induced telomere dysfunction caused fibroblasts to transdifferentiate into α-SMA-expressing myofibroblasts, a mesenchymal and contractile cell type that is critical for wound healing and tissue repair. Despite the presence of dysfunctional telomeres, transdifferentiated cells acquired the ability to contract collagen lattices and displayed a gene expression signature characteristic of functional myofibroblasts. Significantly, the formation of dysfunctional telomeres and downstream p53 signaling was necessary for myofibroblast transdifferentiation, as suppressing telomere dysfunction by expression of hTERT, inhibiting the signaling pathways that lead to stochastic telomere dysfunction, and suppressing p53 function prevented the generation of myofibroblasts in response to TGF-β1 signaling. Furthermore, inducing telomere dysfunction using shRNA against TRF2 also caused cells to develop features that are characteristic of myofibroblasts, even in the absence of exogenous TGF-β1. Overall, our data demonstrate that telomere dysfunction is not only compatible with cell functionality, but they also demonstrate that the generation of dysfunctional telomeres is an essential step for transdifferentiation of human fibroblasts into myofibroblasts.

Indexed as

Cell TransdifferentiationCellular SenescenceDNA DamageHumansMyofibroblastsNADPH Oxidase 4Paracrine CommunicationReactive Oxygen SpeciesSmad3 ProteinTelomeraseTelomereTransforming Growth Factor beta1Tumor Suppressor Protein p53NADPH Oxidase 4Reactive Oxygen SpeciesSmad3 ProteinTelomeraseTERT protein, humanTransforming Growth Factor beta1Tumor Suppressor Protein p53hTERTmyofibroblastSASPsenescencetelomerasetelomereTGF-βtransdifferentiation

Identifiers

PMID30244523
PMCPMC6260909
OpenAlexW2893877805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.